Search Results 711-720 of 19234 for Hemoglobin

1. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; subjects with hemoglobin ≥ 8-9 g/dL may be included with approval from the Medical Monitor;; In subjects transfused before study entry ...

2. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica - Mayo Clinic

   Hemoglobin < 8.0 g/dL (International System of Units (SI): < 80 g/L);; White blood cells < 3.0 x 10^3 cells/mm^3 (SI: < 3.0 x 10^9 cells/L);; Neutrophils ...

3. Metabolic syndrome - Symptoms & causes - Mayo Clinic

   Having three or more specific risk factors, such as high blood pressure or abdominal fat, boosts your risk of type 2 diabetes and heart disease.

4. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   hemoglobin ≥9 g/dL;; serum bilirubin ≤1.5 × upper limit of normal (ULN) or ≤ × ULN for patients with Gilbert's disease;; CrCl ≥30 mL/min as measured by 24 ...

5. Publications - Eapen K. Jacob, M.D. - Mayo Clinic

   Filter failures with sickling hemoglobin. Transfusion. 2009 Aug; 49(8):1535-6. View PubMed; Jacob EK, Edwards WD, Zucker M, D'Cruz C, Seshan SV, Crow FW ...

6. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Disease (PF-ILDs) - Mayo Clinic

   DLCO ≥ 25% of predicted normal corrected for hemoglobin (Hb) at Visit 1. 7. Women of childbearing potential (WOCBP) must be ready and able to use highly ...

7. A Study of the Effectiveness of Sulfasalazine in Preventing Acute Diarrhea in Patients with Cancer who are Undergoing Pelvic Radiation Therapy - Mayo Clinic

   Life expectancy ≥ 6 months; Hemoglobin ≥ 10.0 g/dL; Leukocytes ≥ 3,500/mm^3; ANC ≥ 1,500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 1.5 times upper ...

8. Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Hemoglobin > 8.0 gm/dL; Total bilirubin within normal limits. Ejection fraction by MUGA scan or echocardiogram ≥ lower limit of institutional normal ...

9. A Study of JNJ-68284528, a Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ECOG Performance Status grade of 0 or 1. Clinical laboratory values meeting the following criteria during the Screening Phase: HEMOTOLOGY. Hemoglobin. ≥ 8.0 ...

10. A Trial of RAdium-223 and SABR Versus SABR for oligomEtastatic Prostate caNcerS (RAVENS) - Mayo Clinic

    Hemoglobin ≥ 10 g/dL. Patient must have the ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria.